Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities

Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1199-204. doi: 10.1073/pnas.0811018106. Epub 2009 Jan 14.

Abstract

Intermittent hypoxia (IH) occurs in many pathological conditions including recurrent apneas. Hypoxia-inducible factors (HIFs) 1 and 2 mediate transcriptional responses to low O(2). A previous study showed that HIF-1 mediates some of the IH-evoked physiological responses. Because HIF-2alpha is an orthologue of HIF-1alpha, we examined the effects of IH on HIF-2alpha, the O(2)-regulated subunit expression, in pheochromocytoma 12 cell cultures. In contrast to the up-regulation of HIF-1alpha, HIF-2alpha was down-regulated by IH. Similar down-regulation of HIF-2alpha was also seen in carotid bodies and adrenal medullae from IH-exposed rats. Inhibitors of calpain proteases (ALLM, ALLN) prevented IH-evoked degradation of HIF-2alpha whereas inhibitors of prolyl hydroxylases or proteosome were ineffective. IH activated calpain proteases and down-regulated the endogenous calpain inhibitor calpastatin. IH-evoked HIF-2alpha degradation led to inhibition of SOD2 transcription, resulting in oxidative stress. Over-expression of transcriptionally active HIF-2alpha prevented IH-evoked oxidative stress and restored SOD2 activity. Systemic treatment of IH-exposed rats with ALLM rescued HIF-2alpha degradation and restored SOD2 activity, thereby preventing oxidative stress and hypertension. These observations demonstrate that, unlike continuous hypoxia, IH leads to down-regulation of HIF-2alpha via a calpain-dependent signaling pathway and results in oxidative stress as well as autonomic morbidities.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apnea / enzymology*
  • Apnea / mortality
  • Autonomic Nervous System / drug effects
  • Autonomic Nervous System / pathology
  • Basic Helix-Loop-Helix Transcription Factors / metabolism*
  • Calcium Signaling / drug effects
  • Calcium-Binding Proteins / metabolism
  • Calpain / antagonists & inhibitors
  • Calpain / metabolism*
  • Cell Hypoxia / drug effects
  • Down-Regulation / drug effects
  • Enzyme Activation / drug effects
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Male
  • Oligopeptides / administration & dosage
  • Oligopeptides / pharmacology
  • Oxidative Stress* / drug effects
  • PC12 Cells
  • Protein Binding / drug effects
  • Protein Processing, Post-Translational* / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase / antagonists & inhibitors

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Calcium-Binding Proteins
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Oligopeptides
  • calpain inhibitor 2
  • endothelial PAS domain-containing protein 1
  • calpastatin
  • Superoxide Dismutase
  • Calpain